Editorial: Discovery of small molecule lead compounds: a driving force to unravel new anti-cancer targets and mechanisms, volume III - Top-Institutions - MDSpire

Editorial: Discovery of small molecule lead compounds: a driving force to unravel new anti-cancer targets and mechanisms, volume III

  • By

  • Yan Zhang

  • Leilei Fu

  • Yinu Wang

  • May 27, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    National Cancer Institute
    National Cancer Institute

    Bethesda, MD

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

Original Source(s)

Editorial: Discovery of small molecule lead compounds: a driving force to unravel new anti-cancer targets and mechanisms, volume III

  • by Yan Zhang, Leilei Fu, Yinu Wang

  • May 27, 2026

Related Content

Artificial intelligence for optimization of immunotherapy: current applications and transformative potential

Gastric-type endocervical adenocarcinoma with Peutz-Jeghers syndrome: a case report and literature review

Potential targets for boron transport in boron neutron capture therapy